Alg13 - ALG13, UDP-N-acetylglucosaminyltransferase subunit Gene
Species: Rattus norvegicus
Summary
Predicted to enable N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity and thiol-dependent Deubiquitinase. Predicted to be involved in dolichol-linked oligosaccharide biosynthetic process and proteolysis. Predicted to act upstream of or within negative regulation of TORC1 signaling; negative regulation of neuron death; and regulation of synaptic plasticity. Predicted to be located in cytoplasm. Human ortholog(s) of this gene implicated in developmental and epileptic encephalopathy 36. Orthologous to human ALG13 (ALG13 UDP-N-acetylglucosaminyltransferase subunit). [provided by Alliance of Genome Resources, Apr 2022]
Alg13 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001013951.1 | NP_001013973.1 | UDP-N-acetylglucosamine transferase subunit ALG13 homolog |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
UDP-N-acetylglucosamine transferase subunit ALG13 homolog |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS22385 | Alg13 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS00590 | ALG13 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28909 | Alg13 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service